We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CYTH market cap is 28.64M. The company's latest EPS is USD -0.8823 and P/E is -1.43.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 452k | 187k | 152k | 118k | 495k |
| Operating Income | -4.25M | -4.98M | -5.01M | -4.63M | -4.77M |
| Net Income | -4.25M | -4.98M | -5.01M | -4.63M | -4.77M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.01M | 903k | 1.59M | 1.38M | 1.08M |
| Operating Income | -7.39M | -8.96M | -14.27M | -15.62M | -20.05M |
| Net Income | -7.53M | -8.94M | -14.29M | -15.45M | -20.06M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.49M | 4.22M | 4.1M | 4.64M | 5.6M |
| Total Liabilities | 2.88M | 3.48M | 4.54M | 6.13M | 6.65M |
| Total Equity | 5.61M | 734k | -439k | -1.49M | -1.05M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.11M | 14.19M | 19.52M | 4.22M | 13.25M |
| Total Liabilities | 3.18M | 3.74M | 3.85M | 3.48M | 8.49M |
| Total Equity | 936k | 10.45M | 15.67M | 734k | 4.76M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.37M | -15.12M | -4.37M | -7.85M | -11.89M |
| Investing | 38k | 38k | N/A | N/A | N/A |
| Financing | 7k | 7k | 3.74M | 7.15M | 12.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.59M | -8.54M | -15.01M | -15.12M | -16.18M |
| Investing | 36k | -14k | 14k | 38k | -2k |
| Financing | 7.12M | 18.62M | 18.76M | 7k | 23.89M |
| Market Cap | 28.64M |
| Price to Earnings Ratio | -1.43 |
| Price to Sales Ratio | 26.64 |
| Price to Cash Ratio | 3.1 |
| Price to Book Ratio | 6.02 |
| Dividend Yield | - |
| Shares Outstanding | 22.73M |
| Average Volume (1 week) | 36.65k |
| Average Volume (1 Month) | 100.6k |
| 52 Week Change | 29.90% |
| 52 Week High | 2.57 |
| 52 Week Low | 0.8924 |
| Spread (Intraday) | 0.11 (8.09%) |
| Company Name | Cyclo Therapeutics Inc |
| Address |
6714 nw 16th street gainesville, florida 32653 |
| Website | https://www.cyclotherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
